Literature DB >> 12375720

Outpatient parenteral antibiotic therapy: evolution of the Calgary adult home parenteral therapy program.

Kevin B Laupland1, M John Gill, Linda Schenk, Diane Goodwin, H Dele Davies.   

Abstract

In the past 25 years, outpatient antibiotic therapy has been recognized as a cost-effective, safe and patient-accepted means of managing patients with chronic infections who require prolonged parenteral therapy but otherwise do not need admission to hospital. We describe the home parenteral therapy program in Calgary, which reflects the next generation of outpatient antibiotic therapy in Canada because of its unique inclusion of patients with acute infections. The Calgary home parenteral therapy program has evolved from a few, small, single-site programs to a multisite, region-wide program that each year treats thousands of patients who require long- and short-term parenteral therapy. With escalating health care budgets and increased demand on acute-care hospital beds, existing programs in other centres may benefit from the Calgary experience, and this home parenteral therapy model may serve as a template for developing new outpatient antibiotic therapy programs in other regions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375720

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  8 in total

1.  Outpatient parenteral antimicrobial therapy.

Authors:  Kevin B Laupland; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

2.  Blood cultures in ambulatory outpatients.

Authors:  Kevin B Laupland; Deirdre L Church; Daniel B Gregson
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

3.  Burden of community-onset bloodstream infection: a population-based assessment.

Authors:  K B Laupland; D B Gregson; W W Flemons; D Hawkins; T Ross; D L Church
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

4.  Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI).

Authors:  Aric J Storck; Kevin B Laupland; Ronald R Read; Manuel W Mah; John M Gill; Deborah Nevett; Thomas J Louie
Journal:  BMC Infect Dis       Date:  2006-10-11       Impact factor: 3.090

Review 5.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

6.  Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.

Authors:  William J Connors; Heidi H Rabie; Rafael L Figueiredo; Donna L Holton; Michael D Parkins
Journal:  BMC Infect Dis       Date:  2017-03-09       Impact factor: 3.090

7.  Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.

Authors:  Marie Yan; Marion Elligsen; Andrew E Simor; Nick Daneman
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-02-22       Impact factor: 2.471

8.  The Validation of a Novel Surveillance System for Monitoring Bloodstream Infections in the Calgary Zone.

Authors:  Jenine R Leal; Daniel B Gregson; Deirdre L Church; Elizabeth A Henderson; Terry Ross; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-07       Impact factor: 2.471

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.